Hepatocellular carcinoma: a clinical and pathological overview

Area of Science:

• Hepatology
• Oncology
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) incidence has risen significantly over the last 30 years.
• Projections indicate over 1 million new HCC cases annually by 2025.
• Molecular profiling has revealed distinct HCC subclasses.

Purpose of the Study:

• To review the impact of molecular subtyping on understanding Hepatocellular carcinoma (HCC).
• To discuss how advanced characterization influences patient management strategies.

Main Methods:

• Review of high-throughput sequencing technologies.
• Analysis of molecular and phenotypical features of HCC subclasses.
• Pathological characterization of Hepatocellular carcinoma.

Main Results:

• Identification of two major molecular subgroups within HCC.
• Association of specific morphological and phenotypical features with these subgroups.
• Growing knowledge base regarding HCC heterogeneity.

Conclusions:

• Molecular subtyping provides a more precise characterization of Hepatocellular carcinoma.
• Enhanced pathological understanding is expected to significantly impact HCC patient management.
• Future clinical decisions will likely be informed by detailed molecular and pathological profiles.